Post Graduate Program for Executives - Managing Business in India and China (PGPEx- MBIC)

Course Highlights

The Executive Management Program aims at equipping the participants with adequate knowledge and business skills for managing businesses in India and China, and also enabling them to operate at strategic levels with a global outlook by synergizing all functional areas of Management. Moreover the participants will be trained in Chinese language, Chinese Culture and Chinese tradition understanding which is important for doing business in China.

Exams Taken
Work Experience
60 months
Admissions Process

Following are the basic criteria for the PGPEx-(MBIC) Application and admission process: 

  • - All the applicants must have at least a bachelor degree in any discipline from a recognized University. 
  • - CAT (Overall percentile of the test taken in either of the years 2017 or 2018) and/ GMAT (Valid score since the last three years)
  • - Work Experience of managerial/ supervisory roles (05 years and above is desirable).
  • - Relaxations may be granted for candidates with strong managerial/supervisory role experience
  • - The timeline for online application is from 1st week, March 2019 to Last week of April 2019
  • - Shortlisted candidates would be called for attending the Executive Assessment Center (EAC)
  • - Final selection list will be announced in last week of June 2019

Last Date to Apply: April 30, 2019

Important Dates
Last date to apply:
Not available yet
Cut off accepted:
85.00 percentile
Last date to apply:
Not available yet
Cut off accepted:
Not available
Cut off score:
Interview & GD Process
Executive Assessment Center (EAC) | Personal Interview
Seats: 30


Placement 2017

Average Salary: 18,40,000 per annum
Highest Salary: 20,50,000 per annum
Top Recruiters: JK Technosoft, HILTI India, Cognizant, IndusInd Bank, Capgemini, E&Y, Star Cement, JP Morgan Chase, Reliance Industries, Tata Insights, Shapoorji Pallonji, Damodar Valley Corporation, TCS, dun&bradstreet, KPMG, Aditya Birla Group, Tech Mahindra, L&T, DS Group, HPCL, MU Sigma, NOVARTIS